缅北强奸

Dr Wassim Kassouf completed a clinical and research fellowship in urologic oncology at M. D. Anderson Cancer Center in Houston, Texas following medical school and urology residency at 缅北强奸. He then arrived back on faculty at the 缅北强奸 Health Center in 2006. Dr. Kassouf鈥檚 clinical practice focuses on all aspects of urologic oncology (including bladder, prostate, renal, and testes cancer) whereas his research focuses on bladder cancer. Presently, he is the Program Director of the 缅北强奸 Urology Residency. He also serves as the chair of the MUHC Urology Quality of Care Assurance committee and a member of the Royal College Urology Specialty committee as well as the Royal College Examination board committee.聽

He has led several national guidelines for optimizing quality of care in urologic cancer management and has published over 230 peer-review manuscripts and book chapters. He has obtained independent peer-reviewed grant funding from the CRS and CIHR. He is an associate editor for BMC Urology and is on the editorial board of Urology, CUAJ, Clinical Cancer Investigation Journal, and International Brazilian Journal of Urology. He is a course director on bladder and upper tract cancers at the SIU and AUA. He is the founder of the national Canadian Bladder Cancer Network, a cofounder of Bladder Cancer Canada, chair of the National Cancer Institute of Canada鈥檚 disease-oriented group in bladder cancer, Vice-President (communications) of the Canadian Urological Association, and an executive member of the NIH Genitourinary steering committee Bladder Cancer Task Force. Dr Kassouf is a graduate of the AUA Leadership Program and received several awards including the American Urological Association Research Scholar Award, Canadian Urological Association Scholarship Award, FRSQ Clinician Scientist Research Scholar Award, and the Everett C. Reid Teaching Excellence Award.